SpectraCure AB is a Swedish company founded in 2003 as a spin-off from Lund University’s Medical Laser Centre and Atomic Physics Division. We are active in the area of cancer treatments utilizing a light source and a phonosensitizing drug, so called photodynamic therapy and interstitial photodynamic therapy as well as thermal therapy These therapies are suitable for treatment of solid cancer tumors in different parts of the body, for example prostate, pancreas and ear, nose and throat.

The earliest recorded treatments that exploited a photosensitizer and a light source, in this case sunlight, for medical effect can be found in ancient Egyptian and Indian sources. And the first detailed scientific evidence that agents, photosensitive synthetic dyes, in combination with a light source and oxygen could have potential therapeutic effect was made at the turn of the 20th century in the laboratory of von Tappeiner in Munich, Germany.

Since then the development has taken big leaps forward. One hurdle that has hindered many researchers to further the development has been how to control the light in order to expose the tumor with the exact amount of light to achieve maximum effect. SpectraCure has developed its sophisticated software IDOSE® to do just that..

How does it work?
By combining a light activated drug with light of a certain wavelength a reaction occurs that causes cell death. IDOSE® makes sure the light is controlled.


Read more

Watch the video

What is IPDT?
SpectraCure has developed and patented the software IDOSE® for safe, accurate and efficient cancer IPDT treatment of solid cancer tumors.


Read more